Ricardo Zayas
Corporate Officer/Principal bei CATALENT, INC.
Vermögen: 347 243 $ am 30.04.2024
Profil
Ricardo Zayas is currently the Senior VP-North America Biologic Operations at Catalent, Inc. He previously worked as the Vice President & General Manager-Operations at Wyeth Pharmaceuticals LLC from 2007 to 2009, Senior Vice President-Operations at AMAG Pharmaceuticals, Inc. from 2009 to 2011, and General Manager-Operations at Schering-Plough Pharmaceuticals from 2001 to 2007.
He also held positions as the Chief Operations Officer at Romark Global Pharma LLC and Chief Operating Officer & Operational Lead at OcyonBio.
Mr. Zayas received his undergraduate degree from Kansas State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CATALENT INC
0,00% | 01.08.2023 | 6 223 ( 0,00% ) | 347 243 $ | 30.04.2024 |
Aktive Positionen von Ricardo Zayas
| Unternehmen | Position | Beginn |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | 17.01.2023 |
Ehemalige bekannte Positionen von Ricardo Zayas
| Unternehmen | Position | Ende |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Geschäftsführer | 11.02.2011 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 02.01.2009 |
| Schering-Plough Pharmaceuticals | Corporate Officer/Principal | 02.01.2007 |
| Ocyonbio | Geschäftsführer | - |
Romark Global Pharma LLC
 Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Geschäftsführer | - |
Ausbildung von Ricardo Zayas
| Kansas State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CATALENT, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
| Schering-Plough Pharmaceuticals | |
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Health Technology |
| Ocyonbio |
